NewEdge Advisors’s Monopar Therapeutics MNPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.5K Hold
600
﹤0.01% 2933
2025
Q1
$21.8K Hold
600
﹤0.01% 2834
2024
Q4
$13.2K Hold
600
﹤0.01% 2938
2024
Q3
$4.04K Hold
600
﹤0.01% 3215
2024
Q2
$2.19K Hold
600
﹤0.01% 3318
2024
Q1
$2.04K Buy
+600
New +$2.04K ﹤0.01% 3363